Senior Director of Manufacturing, Lumicell
Supply Chain and CM&C Considerations During Development of Lumicell’s Cleavable PEGylated Peptide-Dye Conjugate for Fluorescence-Guided Surgery
The complex structure of the LUM015 imaging agent presents unique supply chain and quality challenges. We combined several different control strategies and coordinated between several vendors in order to leverage specialized expertise and manage quality and supply chain risk.
Daniel Harris leads the development and manufacturing of Lumicell’s imaging agent. His background is in the development of fluorescent materials for in vivo imaging, lighting and display technologies. He holds a PhD in materials science from MIT.